Urinary 9α, 11β-PGF2 as a marker of mast cell activation in allergic and aspirin-intolerant asthma

Advances in Experimental Medicine and Biology

Volumn 433, Issue , 1997, Pages 159-162

  O'Sullivan, Siobhán ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN G2;

ALLERGIC ASTHMA; ARTICLE; HUMAN; IMMUNOPATHOGENESIS; LEUKOCYTE ACTIVATION; MAST CELL; MAST CELL DEGRANULATION; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROSTAGLANDIN URINE LEVEL;

EID: 0031394118     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1810-9_32     Document Type: Article

References (7)

1. 2 generation after activation of rat and human mast cells with anti-IgE.J Immunol. 129:1627-31 (1982).
2. 2 in a normal human male volunteer. J BiolChem. 260:13172-80. (1985).
3. 2-isoprostanes produced by non-cyclooxygenase free radical-catalysed mechanism. Methods in Enzymology. 233:163-75 (1994).
4. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis. 143:1025-1029. (1991).
5. 2 metabolite 9α,11β-PGP2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol. 98:421-32. (1996).
6. A Roquet, B Dahlén, M Kumlin, E Ihre, G Anstrén, S Binks, S-E Dahĺn. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med. In press ( 1997).
7. Z Diamant, MC Timmers, H van der Veen, BS Friedman, et al. The effect of MK-0591, a novel 5-Lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J Allergy Clin Immunol. 95:42-51. (1995).